 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 4 | 1/1 | 返回列表 |
| 查看: 700 | 回復(fù): 3 | ||
[求助]
前列腺癌細(xì)胞中的RNA序列
|
| 本人不是生物專業(yè)，需要知道前列腺癌PC-3中RNA的序列，不知道如何才能查到，或者大家有知道的幫幫忙吧，謝謝！ |
回復(fù)此樓» 猜你喜歡
263求調(diào)劑
已經(jīng)有4人回復(fù)
-
石河子大學(xué)（211、雙一流）碩博研究生長(zhǎng)期招生公告
已經(jīng)有3人回復(fù)
-
一志愿西安交通大學(xué)材料工程專業(yè) 282分求調(diào)劑
已經(jīng)有13人回復(fù)
-
北科281學(xué)碩材料求調(diào)劑
已經(jīng)有6人回復(fù)
-
328求調(diào)劑，英語(yǔ)六級(jí)551，有科研經(jīng)歷
已經(jīng)有10人回復(fù)
-
298求調(diào)劑
已經(jīng)有6人回復(fù)
-
310求調(diào)劑
已經(jīng)有4人回復(fù)
-
311求調(diào)劑
已經(jīng)有6人回復(fù)
-
307求調(diào)劑
已經(jīng)有11人回復(fù)
-
材料與化工085600，總分304，本科有兩篇sci參與，求調(diào)劑
已經(jīng)有5人回復(fù)
» 本主題相關(guān)價(jià)值貼推薦，對(duì)您同樣有幫助:
- 轉(zhuǎn)錄組研究前沿
已經(jīng)有21人回復(fù)
- 【求助/交流】Hela細(xì)胞中RNA的提取
已經(jīng)有6人回復(fù)
- 誰(shuí)能告訴我怎樣在血液的淋巴細(xì)胞中提RNA
已經(jīng)有8人回復(fù)
lthy888888
金蟲 (小有名氣)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 1240.4
- 帖子: 78
- 在線: 33.3小時(shí)
- 蟲號(hào): 879610
- 注冊(cè): 2009-10-21
- 專業(yè): 中藥質(zhì)量評(píng)價(jià)
2樓2011-09-02 22:42:25
rb
木蟲 (著名寫手)
小笨蟲蟲
- BioEPI: 3
- 應(yīng)助: 44 (小學(xué)生)
- 貴賓: 0.1
- 金幣: 4952.8
- 散金: 1634
- 紅花: 8
- 帖子: 2357
- 在線: 285.2小時(shí)
- 蟲號(hào): 30311
- 注冊(cè): 2003-11-30
- 性別: GG
- 專業(yè): 人類遺傳學(xué)
3樓2011-09-02 23:13:25
rb
木蟲 (著名寫手)
小笨蟲蟲
- BioEPI: 3
- 應(yīng)助: 44 (小學(xué)生)
- 貴賓: 0.1
- 金幣: 4952.8
- 散金: 1634
- 紅花: 8
- 帖子: 2357
- 在線: 285.2小時(shí)
- 蟲號(hào): 30311
- 注冊(cè): 2003-11-30
- 性別: GG
- 專業(yè): 人類遺傳學(xué)
【答案】應(yīng)助回帖
|
如果有錢，你可以買這個(gè)細(xì)胞株，進(jìn)行轉(zhuǎn)錄組測(cè)序或者來(lái)一個(gè)便宜的全基因組表達(dá)譜。當(dāng)然最好根據(jù)你的試驗(yàn)需要好好的設(shè)計(jì)一下試驗(yàn)。 下面是細(xì)胞的簡(jiǎn)介，很多地方都可以買到：） CRL-1435 PC-3 人前列腺癌細(xì)胞 ATCC® Number: CRL-1435™ Designations: PC-3 Depositors: ME Kaighn Biosafety Level: 1 Shipped: frozen Medium & Serum: See Propagation Growth Properties: adherent (The cells form clusters in soft agar and can be adapted to suspension growth) Organism: Homo sapiens (human) Morphology: epithelial Source: Organ: prostate Tumor Stage: grade IV Disease: adenocarcinoma Derived from metastatic site: bone Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. Applications: transfection host (Nucleofection technology from Lonza Roche FuGENE® Transfection Reagents) Tumorigenic: Yes Antigen Expression: HLA A1, A9 DNA Profile (STR): Amelogenin: X CSF1PO: 11 D13S317: 11 D16S539: 11 D5S818: 13 D7S820: 8,11 THO1: 6,7 TPOX: 8,9 vWA: 17 Cytogenetic Analysis: The line is near-triploid with a modal number of 62 chromosomes. There are nearly 20 marker chromosomes commonly found in each cell; and normal N2, N3, N4, N5, N12, and N15 are not found. No normal Y chromosomes could be detected by Q-band analysis. Age: 62 years adult Gender: male Ethnicity: Caucasian Comments: The PC-3 was initiated from a bone metastasis of a grade IV prostatic adenocarcinoma from a 62-year-old male Caucasian. [22363] The cells exhibit low acid phosphatase and testosterone-5-alpha reductase activities. Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated F-12K Medium, Catalog No. 30-2004. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Atmosphere: air, 95%; carbon dioxide (CO2), 5% Temperature: 37.0°C Subculturing: Protocol: Remove and discard culture medium. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting. Add appropriate aliquots of the cell suspension to new culture vessels. Incubate cultures at 37°C. Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended Medium Renewal: 2 to 3 times per week Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO Storage temperature: liquid nitrogen vapor phase Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2004 recommended serum:ATCC 30-2020 References: 22363: Kaighn ME, et al. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol. 17: 16-23, 1979. PubMed: 447482 22470: Chen TR. Chromosome identity of human prostate cancer cell lines, PC-3 and PPC-1. Cytogenet. Cell Genet. 62: 183-184, 1993. PubMed: 8428522 26302: Ohnuki Y, et al. Chromosomal analysis of human prostatic adenocarcinoma cell lines. Cancer Res. 40: 524-534, 1980. PubMed: 7471073 32341: Sheng S, et al. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc. Natl. Acad. Sci. USA 93: 11669-11674, 1996. PubMed: 8876194 32344: Umekita Y, et al. Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride. Proc. Natl. Acad. Sci. USA 93: 11802-11807, 1996. PubMed: 8876218 32460: Carter RE, et al. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc. Natl. Acad. Sci. USA 93: 749-753, 1996. PubMed: 8570628 32486: Nupponen NN, et al. Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization. Cancer Genet. Cytogenet. 101: 53-57, 1998. PubMed: 9460501 32488: Geiger T, et al. Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice. Anticancer Drug Des. 13: 35-45, 1998. PubMed: 9474241 32916: Su ZZ, et al. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. Proc. Natl. Acad. Sci. USA 93: 7252-7257, 1996. PubMed: 8692978 |
4樓2011-09-27 08:47:30
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 llxxdl620 的主題更新
| 4 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 263求調(diào)劑 +4 | yqdszhdap－ 2026-03-22 | 4/200 |
|
|---|---|---|---|---|
|
[考研] 315分，誠(chéng)求調(diào)劑，材料與化工085600 +3 | 13756423260 2026-03-22 | 3/150 |
|
|
|
[考研] 尋找調(diào)劑 +4 | 倔強(qiáng)芒? 2026-03-21 | 4/200 |
|
|
|
[考研] 319求調(diào)劑 +4 | 小力氣珂珂 2026-03-20 | 4/200 |
|
|
|
[考研] 一志愿中南大學(xué)化學(xué)學(xué)碩0703總分337求調(diào)劑 +3 | niko- 2026-03-22 | 3/150 |
|
|
|
[考研] 一志愿北京化工大學(xué)070300 學(xué)碩336求調(diào)劑 +5 | vv迷 2026-03-21 | 8/400 |
|
|
|
[考研] 0805 316求調(diào)劑 +3 | 大雪深藏 2026-03-18 | 3/150 |
|
|
|
[考研] 278求調(diào)劑 +9 | 煙火先于春 2026-03-17 | 9/450 |
|
|
|
[考研] 085601調(diào)劑 358分 +3 | zzzzggh 2026-03-20 | 4/200 |
|
|
|
[考研] 316求調(diào)劑 +6 | 梁茜雯 2026-03-19 | 6/300 |
|
|
|
[考研] 294求調(diào)劑材料與化工專碩 +15 | 陌の森林 2026-03-18 | 15/750 |
|
|
|
[考研] 一志愿南理工085701環(huán)境302求調(diào)劑院校 +3 | 葵梓衛(wèi)隊(duì) 2026-03-20 | 3/150 |
|
|
|
[考研] 281求調(diào)劑（0805） +14 | 煙汐憶海 2026-03-16 | 25/1250 |
|
|
|
[考研] 298-一志愿中國(guó)農(nóng)業(yè)大學(xué)-求調(diào)劑 +9 | 手機(jī)用戶 2026-03-17 | 9/450 |
|
|
|
[考研] 344求調(diào)劑 +6 | knight344 2026-03-16 | 7/350 |
|
|
|
[考研] 材料，紡織，生物（0856、0710），化學(xué)招生啦 +3 | Eember. 2026-03-17 | 9/450 |
|
|
|
[考博] 26博士申請(qǐng) +3 | 1042136743 2026-03-17 | 3/150 |
|
|
|
[考博] 26申博 +4 | 八6八68 2026-03-16 | 4/200 |
|
|
|
[考研] 283求調(diào)劑 +3 | 聽風(fēng)就是雨； 2026-03-16 | 3/150 |
|
|
|
[考研]
 11408 一志愿西電，277分求調(diào)劑
+3
|
zhouzhen654 2026-03-16 | 3/150 |
|